Investors hoping that tax cuts and aggressive government spending plans will add another leg to the bull market likely are going to be disappointed, Morgan Stanley argues in an analysis that contends the end of big returns is near.
Something unexpected just happened… A tiny piece of earth was lobbed into a very deep regulatory black hole.
The Senior Judge of the U.S. District Court for the Western District of Washington, Judge Barbara Jacobs Rothstein, ruled last week that the accounting giant PricewaterhouseCoopers was liable for failing to uncover a multibillion-dollar fraud....More>>>
The technicians love the biotech sector–and the iShares Nasdaq Biotechnology ETF (IBB)–today. Earlier today, we discussed Cornerstone Macro’s Carter Worth, who predicts big upside for the health-care sector generally, and some biotech stocks specifically, Regeneron Pharmaceuticals (REGN) and Amgen (AMGN) among them. Now, the folks at Bespoke Investment Group have published their....More>>>
Paying generous dividends is a classic way for companies to attract stable investors. But just because a company can afford to pay big dividends doesn’t mean that it ever will. Let’s take a look at three companies that have low payout ratios but still pay paltry dividends that are lower than the S&P 500’s yield of 2%.
Small cap diabetes stocks Oramed Pharmaceuticals, Inc (NASDAQ: ORMP), Senseonics Holdings (NYSEMKT: SENS) and Cell MedX Corp (OTCQB: CMXC) might not immediately come to mind when you think of the disease. However, theres plenty of room in the market place for players of all sizes. Just consider some quick statistics about diabetes compiled by Cell MedX Corp:
McDonald’s investors (NYSE:MCD) are celebrating a Trump victory that will usher in an administration far more friendly to businesses. A Republican government may do its part in avoiding things like the golden arch being liable for independent contractor violations or in voiding the penalties faced by employers under the Obamacare mandates.....More>>>
Any time a growth stock like Amazon (NSDQ:AMZN) comes under pressure, value investors come out in droves citing the company’s ridiculously high earnings multiple as reason enough to stay clear of the stock. Growth investors and value investors are two entirely different breeds. One looks for deeply discounted fundamentally strong companies whereas growth investors concentrate a lot on growth....More>>>
The travails and triumphs of the market visited two of its mavens this week, when a PR fiasco sunk Warren Buffett (Trades, Portfolio) stock United Airlines and an unlikely burst occurred in one of Prem Watsa (Trades, Portfolio)’s most stubborn stocks, BlackBerry.
Shares of United Continental Holdings dropped 4.29% on Monday and Tuesday, shaving $88.9 million off of Buffett’s holding....More>>>
On Thursday, our Under the Radar Moversnewslettersuggested smallcap electrical power conversion product stock Ideal Power Inc (NASDAQ: IPWR)as a long trade:
We’re taking a bit of a flyer with Ideal Power, but the upside is worth the risk. While it’s in the red today, if you look closely you’ll see all it took was a brush of all the recently-hurdled moving average lines to....More>>>
Lands’ End (NASDAQ:LE) CMO Gill Brown Hong bought 1,525 shares of the company’s stock in a transaction on Friday, April 13th. The shares were bought at an average price of $22.20 per share, with a total value of $33,855.00. Following the completion of the transaction, the chief marke
Enbridge Energy, Limited Partnership (NYSE:EEP) had its target price lowered by Barclays from $16.00 to $11.00 in a research report sent to investors on Tuesday morning, Marketbeat reports. The brokerage currently has an equal weight rating on the pipeline company’s stock.